Coppell Advisory Solutions’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4
| Closed | -$67 | – | 341 |
|
|
2024
Q4 | $67 | Hold |
4
| – | – | ﹤0.01% | 1921 |
|
|
2024
Q3 | $63 | Hold |
4
| – | – | ﹤0.01% | 1825 |
|
|
2024
Q2 | $65 | Buy |
+4
| New | +$65 | ﹤0.01% | 1745 |
|
|
2023
Q4 | $29K | Buy |
925
+625
| +208% | +$19.6K | 0.01% | 635 |
|
|
2023
Q3 | $4.78K | Hold |
300
| – | – | ﹤0.01% | 721 |
|
|
2023
Q2 | $7.2K | Buy |
+300
| New | +$7.2K | ﹤0.01% | 766 |
|
|
2023
Q1 | – | Sell |
-600
| Closed | -$9.55K | – | 207 |
|
|
2022
Q4 | $9.55K | Buy |
+600
| New | +$9.55K | ﹤0.01% | 620 |
|